Pancreatic Cancer Research

ResearcherMemorial Sloan Kettering Cancer CenterActive in the last 2 years

Taha Merghoub

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-1518-5111; OpenAlex author ID A5002951130; NIH RePORTER profile ID 9805134. Sources: OpenAlex.

Their work

Papers
6
Trials
0
Grants
1
Labs led
0
Collaborators
41
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: 1 paper · 2023: 1 paper · 2024: none · 2025: 2 papers, 1 grant

Papers 6

  1. IL-33-activated ILC2s induce tertiary lymphoid structures in pancreatic cancer. Co-author DOI 10.1038/s41586-024-08426-5↗
  2. RNA neoantigen vaccines prime long-lived CD8+ T cells in pancreatic cancer. Co-author DOI 10.1038/s41586-024-08508-4↗
  3. Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer. Co-author DOI 10.1038/s41586-023-06063-y↗
  4. Neoantigen quality predicts immunoediting in survivors of pancreatic cancer. Co-author DOI 10.1038/s41586-022-04735-9↗
  5. iNOS Regulates the Therapeutic Response of Pancreatic Cancer Cells to Radiotherapy. Co-author DOI 10.1158/0008-5472.can-19-2991↗
  6. Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer. Co-author DOI 10.1038/nature24462↗

Grants 1

  1. Group 2 Innate Lymphoid Cell Regulation of Pancreatic Cancer Immunity R01CA262516↗

Closest collaborators

The 25 strongest of 41 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Vinod P. Balachandran · 4 shared papers, 1 shared grant, 2017–2025 · strength 1.53
  2. Benjamin D. Greenbaum · 4 shared papers, 2017–2025 · strength 0.46
  3. Zachary M. Sethna · 3 shared papers, 2022–2025 · strength 0.42
  4. Luis Alfonso Rojas · 3 shared papers, 2022–2025 · strength 0.42
  5. Kevin C. Soares · 3 shared papers, 2022–2025 · strength 0.42
  6. Masataka Amisaki · 3 shared papers, 2022–2025 · strength 0.42
  7. Akihiro Ohmoto · 2 shared papers, 2025 · strength 0.32
  8. Jedd D. Wolchok · 3 shared papers, 2017–2025 · strength 0.30
  9. Christine A. Iacobuzio–Donahue · 3 shared papers, 2017–2022 · strength 0.25
  10. Olca Baştürk · 2 shared papers, 2017–2025 · strength 0.20
  11. Ryan Sugarman · 1 shared paper, 2025 · strength 0.15
  12. Anna M. Varghese · 1 shared paper, 2025 · strength 0.15
  13. Özlem Türeci · 1 shared paper, 2025 · strength 0.15
  14. T. Peter Kingham · 1 shared paper, 2025 · strength 0.15
  15. Michael Ian D'Angelica · 1 shared paper, 2025 · strength 0.15
  16. Ira Mellman · 1 shared paper, 2025 · strength 0.15
  17. Wungki Park · 1 shared paper, 2025 · strength 0.15
  18. Eileen Mary O'Reilly · 1 shared paper, 2025 · strength 0.15
  19. Uğur Şahin · 1 shared paper, 2025 · strength 0.15
  20. Andrew S. Epstein · 1 shared paper, 2025 · strength 0.15
  21. Jeffrey A. Drebin · 1 shared paper, 2025 · strength 0.15
  22. Elizabeth S. Won · 1 shared paper, 2025 · strength 0.15
  23. William R. Jarnagin · 1 shared paper, 2025 · strength 0.15
  24. Alice Chia-Chi Wei · 1 shared paper, 2025 · strength 0.15
  25. Marta Łuksza · 2 shared papers, 2017–2022 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.